Skip to content
← Survival collections

POPULATION SURVIVAL

HR+/HER2+ Breast Cancer (Female only)

Published source values

Female · All Ages · All Stages · All Races / Ethnicities

Source
SEER
Table
Recent Trends
Data submission
November 2025 submission
Application release
Updated
June 22, 2026
Retrieved
Diagnosis years
2010 to 2022
5-year Relative Survival by diagnosis year for HR+/HER2+ Breast Cancer (Female only). Source table: SEER Recent Trends.
Diagnosis yearRelative survival (%)Lower CIUpper CIStandard errorModeled (%)Source count
201090.69720889.72172091.5845040.47458390.4193226520
201190.86311289.91383091.7272050.46200390.6293986805
201290.02268889.09085690.8790500.45570990.8351067143
201390.60802489.70884591.4324330.43921491.0365257400
201491.40426290.55286792.1822730.41517191.2337338163
201591.42338590.58710092.1886070.40807691.4268108506
201691.21468790.38350691.9772510.40612891.6158328696
201792.08981491.26825892.8371340.39969191.8008778648
201892.47794391.64156493.2337460.40554691.9820188487
2019Not publishedNot publishedNot publishedNot published92.159331Not published
2020Not publishedNot publishedNot publishedNot published92.332888Not published
2021Not publishedNot publishedNot publishedNot published92.502761Not published
2022Not publishedNot publishedNot publishedNot published92.669022Not published

Open the SEER source

Filters stay in your browser. Some combinations have no estimate.

SEER · SOURCE POPULATIONS

Recent survival trends

Compare diagnosis years, not years since diagnosis. These estimates describe different diagnosis eras—not one person’s changing outlook.

Loading the exact source populations…

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Relative survival compares cancer populations with the general population. It is not the percentage of people alive, a treatment effect, or a personal forecast. Diagnosis-period dates were not labeled in the recovered package; see the source notes below.